Congenital renal disorder
(UMLS:C0543793)
- UMLS ID:
- C0543793
- MeSH ID:
- N/A
Synonym(s)
1.
Congenital renal disorder
2.
Congenital kidney disease or syndrome
3.
RENAL DISEASE CONGENITAL
4.
congenital disorders kidney
5.
congenital kidney disorder
6.
congenital renal disorder
7.
congenital renal disorders
Associated Drug(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Ondansetron | FAERS: 15 | US FAERS | |
| 2 | Paroxetine | FAERS: 8 | US FAERS | |
| 3 | Methotrexate | FAERS: 4 | US FAERS | |
| 4 | Fluoxetine | FAERS: 3 | US FAERS | |
| 5 | Sertraline | FAERS: 3 | US FAERS | |
| 6 | 4-hydroxybutyric acid | FAERS: 2 | US FAERS | |
| 7 | Losartan | FAERS: 2 | US FAERS | |
| 8 | Tinzaparin | FAERS: 2 | US FAERS | |
| 9 | Valsartan | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 10 | Citalopram | FAERS: 1 | US FAERS | |
| 11 | Clonazepam | FAERS: 1 | US FAERS | |
| 12 | Desvenlafaxine Succinate | FAERS: 1 | US FAERS | |
| 13 | Fluconazole | FAERS: 1 | US FAERS | |
| 14 | Hydroxyzine | FAERS: 1 | US FAERS | |
| 15 | Isotretinoin | FAERS: 1 | US FAERS | |
| 16 | Lamotrigine | FAERS: 1 | US FAERS | |
| 17 | Lansoprazole | FAERS: 1 | US FAERS | |
| 18 | Levetiracetam | FAERS: 1 | US FAERS | |
| 19 | Lorazepam | FAERS: 1 | US FAERS | |
| 20 | Losartan | FAERS: 1 | US FAERS | |
| 21 | Naproxen | FAERS: 1 | US FAERS | |
| 22 | Olmesartan Medoxomil | FAERS: 1 | US FAERS | |
| 23 | Paroxetine | FAERS: 1 | US FAERS | |
| 24 | Rivastigmine | FAERS: 1 | US FAERS | |
| 25 | Telmisartan | FAERS: 1 | US FAERS | |
| 26 | Valproic Acid | FAERS: 1 | US FAERS | |
| 27 | candesartan cilexetil | FAERS: 1 | US FAERS | |
| 28 | candesartan | FAERS: 1 | US FAERS | |
| 29 | eprosartan | FAERS: 1 | US FAERS | |
| 30 | etonogestrel | FAERS: 1 | US FAERS | |
| 31 | treprostinil | FAERS: 1 | US FAERS |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.